Rare diseases
Investigational molecules
Locations
A Randomized Controlled Trial of Cannabidiol vs Placebo Augmentation in Patients with First Episode Psychosis
GermanyDalbavancin versus standard drug combination for treatment of infective endocarditis caused by Gram‑positive cocci in adult patients
GermanySafety and Tolerability of Intrathecal ION337 in Patients with Dravet Syndrome
GermanyPhase 3 Study of Taletrectinib as Adjuvant Therapy in Patients with Completely Resected ROS1‑Positive Stage IB‑IIIA Non‑Small Cell Lung Cancer
GermanyLong‑Term Safety and Tolerability of Treprostinil Palmitil Inhalation Powder in Patients with Pulmonary Hypertension Associated with Interstitial Lung Disease
GermanySafety and efficacy of rilvegostomig with drug combination in adult patients with unresectable stage III non‑small cell lung cancer undergoing chemoradiotherapy
GermanyColchicine after Electrocardioversion to Prevent Recurrence of Atrial Fibrillation in Adult Patients
GermanyEfficacy and Safety of SIL204 Combined with Standard Chemotherapy in Patients with Locally Advanced Pancreatic Cancer
GermanyPharmacokinetics, Safety, and Immunogenicity of Subcutaneous Ocrelizumab in Children and Adolescents with Relapsing‑Remitting Multiple Sclerosis
GermanyLong‑Term Safety, Tolerability and Efficacy of Azetukalner in Patients with Major Depressive Disorder
GermanyEfficacy of asciminib in chronic phase chronic myeloid leukemia patients with T315I mutation
GermanyA Study of SAR445399 in Adults Aged 18‑80 with Non‑cystic Fibrosis Bronchiectasis
GermanyTell us about your condition – we search every trial in Europe and connect you with the right site.
